Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection
Detection Principle
NucleicAcid-PCR based
Target
E, RdRP
Testing Method Category
PCR_KIT
Testing Method
Kit and WHO-5
Testing Method - Additional Info
Comparison with WHO recommended RT-PCR (WHO-5) and QIAstat-SARS
Reported Performance
LOD: 1000 copies/mL; sensitivity: 100%; specificity: 93%
Sample Size
69 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements